GCM
PCVX icon

Graham Capital Management’s Vaxcyte PCVX Stock Holding History

Graham Capital Management’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$646K Buy
+11,107
New +$603K 0.01% 624
2023
Q4 		– Sell
-7,082
Closed -$361K – 1251
2023
Q3 		$361K Sell
7,082
-3,467
-33% -$171K 0.01% 659
2023
Q2 		$527K Buy
+10,549
New +$500K 0.02% 543

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Graham Capital Management's PCVX Position: Q2 2026 in Review

Graham Capital Management opened a new position in Vaxcyte (PCVX) in Q2 2026: 11,107 shares worth $646K. The stake represents 0.01% of the portfolio and ranks #624 among its holdings. This is a return to the name: Graham Capital Management previously reported a position in PCVX as recently as Q3 2023.

Graham Capital Management first reported a position in PCVX in Q2 2023 and has held it in 3 quarters since. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • Graham Capital Management held 11,107 shares of Vaxcyte worth $646K as of Q2 2026.
  • Vaxcyte was a new Graham Capital Management position in Q2 2026.
  • Vaxcyte made up 0.01% of Graham Capital Management's portfolio in Q2 2026, its #624 holding.
  • Graham Capital Management first reported a position in Vaxcyte in Q2 2023 and has held it in 3 quarters since.
  • 331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Graham Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.